Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
2017 · Cancer Immunology Research · 543 citations
https://doi.org/10.1158/2326-6066.cir-16-0325
K
Katy K. Tsai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
184
Papers
5.2K
Citations
27
h-index
48
i10-index
Katy K. Tsai is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & CAR-T cell therapy research & Immunotherapy and Immune Responses. The author has an h-index of 27, co-authored 157 publications.
Papers by this author
worksClinical outcomes in metastatic uveal melanoma treated with PD‐1 and PD‐L1 antibodies
2016 · Cancer · 367 citations
https://doi.org/10.1002/cncr.30258
Systemic Therapy for Melanoma: ASCO Guideline Update
2023 · Journal of Clinical Oncology · 175 citations
https://doi.org/10.1200/jco.23.01136
Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy
2017 · British Journal of Cancer · 128 citations
https://doi.org/10.1038/bjc.2017.70
Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies
2021 · Circulation Research · 113 citations
https://doi.org/10.1161/circresaha.120.315894
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024
2024 · Journal of the National Comprehensive Cancer Network · 100 citations
https://doi.org/10.6004/jnccn.2024.0036
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat